Abstract
The prevalence of thyroid dysfunction in T1DM is higher than in general population [1–3]. Unrecognized thyroid dysfunction may impair metabolic control of diabetes [2, 4, 5]. Substantial proportion of patients with T1DM develop microangiopathic complications [6]. The significance of the coexisting comorbidity of AITD and T1DM in assessment of the risk of development of diabetic microangiopathy is unknown. The aim of the present study was to determine the association between anti-thyroid antibody positivity and the presence of microangiopathy in adults with T1DM without prior evidence of the thyroid disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
